Hereditary spastic paraplegia: Genetic heterogeneity and common pathways

Area of Science:

• Neurology
• Genetics
• Molecular Biology

Background:

• Hereditary Spastic Paraplegias (HSPs) are a diverse group of rare neurological disorders.
• Characterized by progressive spasticity and weakness in the lower limbs due to corticospinal tract axon degeneration.
• Despite 87 described forms and 73 identified genes, molecular diagnostic rates range from 29% to 61.8%.

Purpose of the Study:

• To highlight the genetic heterogeneity and diagnostic challenges in HSPs.
• To explore potential common pathophysiological pathways for therapeutic targeting.
• To investigate the overlap of HSP genes with other neurological conditions.

Main Methods:

• Review of current literature on HSP genetics and pathophysiology.
• Analysis of reported gene mutations, inheritance patterns, and diagnostic rates.
• Functional convergence of protein activities encoded by HSP-related genes.

Main Results:

• Significant genetic heterogeneity exists in HSPs, with complex inheritance patterns observed.
• A substantial portion of HSP cases remain undiagnosed molecularly, indicating the need for more causative genes or improved diagnostic approaches.
• Multiple HSP-related genes converge on distinct pathophysiological pathways.

Conclusions:

• Common pathophysiological pathways represent a promising therapeutic target for multiple HSP forms.
• The overlap between HSP genes and those involved in other neurological disorders broadens therapeutic possibilities.
• Further research into novel HSP genes and diagnostic strategies is essential.